Unos estudios muestran que la raza y los ingresos pueden determinar los resultados en el cáncer de sangre
LUNES, 12 de diciembre de 2022 (HealthDay News) — Si alguien desarrolla un cáncer de la sangre o un coágulo sanguíneo potencialmente letal, es probable que le vaya mejor si es blanco y rico, muestran tres estudios recientes.El impacto continuo de la …
Learn MoreRace, Income Can Determine Blood Cancer Outcomes, Studies Show
MONDAY, Dec. 12, 2022 (HealthDay News) — If someone is stricken with a blood cancer or life-threatening clot, they’ll probably fare better if they are white and wealthy, three new studies show.The ongoing impact of patient race and income to medical …
Learn MoreAdherence to Quality Indicators Low in Chronic Myeloid Leukemia
WEDNESDAY, Nov. 23, 2022 (HealthDay News) — For newly diagnosed chronic-phase chronic myeloid leukemia (CML) patients, adherence to guideline-based quality indicators is low, according to a study published online Nov. 11 in Leukemia & Lymphoma.Genevi…
Learn MoreCesarean Section Tied to Higher Risk for Later Leukemia in Offspring
THURSDAY, Sept. 15, 2022 (HealthDay News) — Elective cesarean section (CS) is associated with an increased risk for leukemia in offspring, according to a systematic review and meta-analysis published online Aug. 24 in Hematological Oncology.Yingzhu Y…
Learn MorePolypharmacy Prevalent Among Older Adults With Blood Cancers
THURSDAY, Aug. 11, 2022 (HealthDay News) — For older adults with blood cancers, taking eight or more medications is associated with frailty, according to a study published in the August issue of the Journal of the National Comprehensive Cancer Netw…
Learn MoreHigher Tisagenlecleucel Doses May Improve Outcomes in Youth With B-ALL
TUESDAY, Aug. 9, 2022 (HealthDay News) — For pediatric patients with B-cell acute lymphoblastic leukemia, higher doses of tisagenlecleucel, the chimeric antigen receptor T (CAR T)-cell therapy targeting CD19, are associated with improved survival, ac…
Learn MoreFor Blood Cancer Patients, COVID Boosters Can Bring Some Immunity
MONDAY, July 11, 2022 (HealthDay News) — In a promising development, new research has discovered that most adults with blood cancers develop at least some immunity to COVID-19 after getting booster shots.”Our findings build on the wealth of literatur…
Learn MoreUna leucemia agresiva es mucho más letal en los pacientes negros que en los blancos. ¿Por qué?
JUEVES, 7 de julio de 2022 (HealthDay News) — Recibir un diagnóstico de un cáncer de la sangre es devastador para los jóvenes, pero también es mucho más letal si el paciente es negro, muestra una investigación reciente.El nuevo estudio, que observó l…
Learn MoreAn Aggressive Leukemia Is Much More Lethal for Black Patients Than Whites – Why?
THURSDAY, July 7, 2022 (HealthDay News) — Getting a blood cancer diagnosis is devastating for young people, but it is also far more deadly if the patient is Black, new research shows.The new study, which looked at outcomes for patients with acute mye…
Learn More